SequelSEC

ELUTIA INC. ELUT

Biological Products, (No Diagnostic Substances) · CIK 0001708527 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$12.14M
Fiscal year ended 2026-06-30
Operating income
-$26.07M
Fiscal year ended 2026-06-30
Free cash flow
-$46.03M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$65.09MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float / net income1.2×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue5.3×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.4×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Biological Products, (No Diagnostic Substances) filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Net margin434.2%99th
R&D / revenue33.9%18th
CapEx / revenue15.3%78th
Current ratio2.22x29th
Revenue YoY growth-15.0%34th
Gross margin53.7%37th
Operating margin-218.9%59th
FCF margin-379.8%43th
SBC / revenue42.4%51th

ELUTIA INC. (ELUT) reported revenue of $12.14M and net income of $51.81M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from ELUTIA INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).

Income

ELUTIA INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$12.14M
Cost of revenue$5.12M
Gross profit$7.02M
Operating income-$26.07M
Net income$51.81M
Research & development$6.80M
Weighted-average diluted sharesUnavailable
Pretax income-$22.36M
Income tax expense$75.00K
Diluted EPSUnavailable
Selling, general & administrative$21.70M
General & administrative$15.35M
Selling & marketing$6.35M

Balance

ELUTIA INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$19.90M
Total assets$43.65M
Current assets$37.22M
Total liabilities$27.90M
Current liabilities$21.04M
Total equity incl. NCI$15.75M
Temporary (mezzanine) equityUnavailable
Inventory$2.65M
Accounts receivable$1.44M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$3.53M

Cash flow

ELUTIA INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$43.99M
Capital expenditures$2.03M
Investing cash flow$78.83M
Financing cash flow-$23.44M
Net change in cashUnavailable
Stock-based compensation$4.69M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.70M

Derived

ELUTIA INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$46.03M
Gross margin57.8%
Operating margin-214.9%
FCF margin-379.3%
SBC / revenue38.6%
Current ratio1.77x
Revenue YoY growth-0.3%
Net margin426.9%
R&D / revenue56.1%
CapEx / revenue16.8%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ELUT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-03-13View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

ABOS ABPO ACOG ADAPY ADMA ADPT AGEN AGTX AIM ALEC ALGS ALLO

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.